Costing for Socioeconomic Impact Analysis: Implications of Adopting a Patient's Perspective

Author(s)

Quirland C1, Maza F1, Fuentes J2, Eckford R3, Ubels J4, Seoane O5, Hernandez D4, Hernandez-Villafuerte K3, Pham PD3, Retel V6, Schlander M7
1Arturo Lopez Perez Foundation, Health Technology Assessment Unit, Santiago, RM, Chile, 2Arturo Lopez Perez Foundation, Social Impact Unit, Santiago, RM, Chile, 3German Cancer Research Center (DKFZ), Heidelberg, BW, Germany, 4German Cancer Research Center (DKFZ), Heidelberg, Germany, 5Catalan Institute of Oncology, Barcelona, Spain, 6The Netherlands Cancer Institute, Amsterdam, NH, Netherlands, 7Institute for Innovation & Valuation in Health Care, Wiesbaden, Germany

Presentation Documents

BACKGROUND: Research into the socioeconomic impact of cancer and cancer care from the perspective of patients and their relatives (CP&R) has been highly heterogeneous and has been hampered by an absence of standards for measuring their objective financial burden.

OBJECTIVES: Our aim is to contribute to the development of costing principles for effective socioeconomic impact research from the perspective CP&R, linked to established health economic theory.

METHODS: Based upon a scoping review of current recommendations on costing from the perspective of CP&R (search on Medline, Embase, INAHTA and ISPOR pharmacoeconomic guidelines database), a subgroup of the Consensus Task Force on Socioeconomic Impact Analysis of the Organisation of European Cancer Institutes (OECI) identified the need for adaptations to reflect the CP&R perspective in cost measurement.

RESULTS: Valid cost analyses from the perspectives of cancer patients and their relatives should reflect established health economic standards and terminology, including the cost categories proposed by the Washington Panels I (Gold et al., 1996) and II (Neumann et al., 2015). Existing methodological standards need to be adhered to, including but not limited to the process of identification, quantification, and valuation, and the distinction between bottom-up and top-down approaches. The complexity of adopting a CP&R perspective implies the need for a multi-dimensional framework, considering not only cost categories (e.g., direct/indirect, medical/non-medical), but also proximity from disease and interventions (e.g., patient, household, informal household network), and the continuum of care across stages of the disease (e.g., initial diagnosis, treatment planning, treatment, follow-up, disease-free survival, end-of-life). A multidimensional framework will need to further integrate confounders (e.g., sociodemographic characteristics, self-management behaviors, institutional context), in order to support the research goal to identify vulnerable subgroups.

CONCLUSIONS: A We present a consensus proposal for costing standards for socioeconomic impact research from the perspective of CP&R and provide a checklist for future studies.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

EE74

Topic

Economic Evaluation, Methodological & Statistical Research, Study Approaches

Topic Subcategory

Literature Review & Synthesis, PRO & Related Methods, Work & Home Productivity - Indirect Costs

Disease

SDC: Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×